Investing Investment Strategy

  • Stocks Slump on Greece Worries

    Perspectives on why the markets are lower today and discussing whether a major correction is on the way, with Gordon Charlop, Rosenblatt Securities, and Stephen Guilfoyle, Meridian Equity Partners.

  • It's fixing to be a busy week in the euro zone, and this strategist wants to steer clear.

  • Hunt For Yields in Junk Market

    So many investors are hunting for yields in the junk bond market, there may not be enough supply to keep up with demand. A strategy for finding opportunities, with Jim Casey, JPMorgan.

  • Repricing of Risk Expectations

    A check on the day's market selloff, with John Brady, R.J. O'Brien senior vice president, who says the market is seeing a modest repricing of risk expectations.

  • man_with_stock_chart_200.jpg

    Stock prices have doubled over the past three years, but that still hasn't convinced many Americans to invest in the market.

  • Gold Falls Hard

    CNBC's Bertha Coombs takes a look at the two percent drop in gold, as metals extend losses on the decreased likelihood of QE3.

  • U.S. stock index futures fell sharply Tuesday amid renewed concerns that Greece and its private bondholders would not meet the deadline to complete a debt swap and ahead of the Super Tuesday primaries.

  • market-insider-stocks-to-watch-200.jpg

    Take a look at some of Tuesday morning's early movers:

  • Global Fears Seen in the Markets

    Insight on the fears overseas that are impacting the market, with Yra Harris, Praxis Trading partner, who says the market will always correct itself and traders are waiting for the jobless numbers this week.

  • man_with_chart_200.jpg

    Markets should be poised for a 5 percent correction from their current levels as the global economy remains choked by the ongoing euro zone debt crisis and the rising oil prices pose a threat, a CEO told CNBC Tuesday.

  • pills_prescription_200.jpg

    The bulls were all over Keryx Biopharmaceuticals and AEterna Zentaris Monday amid optimism about their Perifosine drug.

  • Tech Data CEO on Revenue Miss & Growth

    Robert Dutkowsky, Tech Data CEO, discusses why his stock was hammered on a revenue miss, and what lies ahead for his company and the entire tech industry, Mad Money's Cramer.

  • Lightning Round

    You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.

  • How to Play Ascena's Blowout Quarter

    Cramer peeks behind the curtain to find out what's driving Ascena Retail Group's spectacular quarter, and whether investors should buy the stock now or wait for a pullback.

  • Cramer: Why You Should Own DuPont

    Mad Money's Cramer says DuPont is no longer a stodgy old chemical company with a juicy yield, it's one of the most innovative firms out there, and a pioneer in new technology.

  • Cramer Asks, How Important is China?

    Mad Money host Jim Cramer explains how overblown concerns about China gives the market a chance to work off an overbought and unsustainable rally.

  • Fast Money Final Trade

    The Fast Money traders share their final trades of the day.

  • Volatility Playbook: The ETF Play

    Are ETFs systematically buying most VIX futures and should investors stay away? Matt Hougan, ETF Analytics president, weighs in.

  • Money In Motion: Euro Ahead of ECB

    A currency trade ahead of the ECB's policy meeting, with Amelia Bourdeau, Westpac Institutional Bank.

  • Stocks finished off their worst levels Monday but still ended in the red as renewed concerns over Greece and slowing growth in China overshadowed better-than-expected economic news in the U.S.